CytomX Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Great. Well, welcome Sean McCarthy, CEO and Chairman of CytomX Therapeutics to Goldman Sachs Healthcare Conference.
First, welcome.
Questions & Answers
Maybe to start things, for those in the audience and listening who may be newer to the CytomX story, can you give a brief overview of Probody therapeutic platform, masking technology, and why you think it's differentiated?
Well, thanks so much for the invitation to be here. It's great to be at the conference. And this is a very exciting time for our company, CytomX Therapeutics. And the core technology that we have been working on now for a number of years is a platform we call the Probody therapeutic platform. It's a strategy for taking biologics such as antibody therapeutics and engineering them to be masked in a way that allows for unmasking in the tumor microenvironment.
And the unmasking happens specifically and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
